Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
2(50.0%)
4Total
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03742141Not ApplicableCompleted

Intraoperative Video Laryngoscopy as Adjunct for Nerve Monitoring

Role: collaborator

NCT00348127Phase 1Completed

A Singapore Pilot Study to Assess Neurovision in Treatment of Low Myopia

Role: collaborator

NCT00348218Phase 1Completed

Pilot Study of Neurovision to Improve Vision and Slow Myopia Progression in Children With Myopia

Role: collaborator

NCT00348075Not ApplicableCompleted

A Singapore Study to Assess How Neurovision Improve the Vision of Adults With Low to Moderate Myopia

Role: collaborator

All 4 trials loaded